More than half of payers, 58%, had at least one outcomes-based contract (OBC) in place during the 2022 plan year, and respondents to a new Avalere survey who are utilizing at least one OBC indicated oncology, cardiology, and endocrinology as the top therapeutic areas in which OBCs came into play last year.